Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial

BACKGROUND: Acute pancreatitis is the most common major complication after endoscopic retrograde cholangiopancreatography (ERCP). Many drugs have been evaluated for prophylaxis, including nonsteroidal anti-inflammatory drugs (NSAIDs), which are potent inhibitors of phospholipase A(2) and play a role...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrade-Dávila, Víctor Fernando, Chávez-Tostado, Mariana, Dávalos-Cobián, Carlos, García-Correa, Jesús, Montaño-Loza, Alejandro, Fuentes-Orozco, Clotilde, Macías-Amezcua, Michel Dassaejv, García-Rentería, Jesús, Rendón-Félix, Jorge, Cortés-Lares, José Antonio, Ambriz-González, Gabriela, Cortés-Flores, Ana Olivia, Alvarez-Villaseñor, Andrea del Socorro, González-Ojeda, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508969/
https://www.ncbi.nlm.nih.gov/pubmed/26195123
http://dx.doi.org/10.1186/s12876-015-0314-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508969/
https://www.ncbi.nlm.nih.gov/pubmed/26195123
http://dx.doi.org/10.1186/s12876-015-0314-2

Ejemplares similares